Protagonist Therapeutics Director Buys, Sells Shares Amid Recent Price Volatility.

viernes, 6 de febrero de 2026, 5:23 pm ET1 min de lectura
PTGX--

Protagonist Therapeutics, Inc. (PTGX) has disclosed that Director Waddill William D. made a purchase of 20,000 shares at a price of $8.31 per share on February 6, 2026. Additionally, the same individual sold 20,000 shares at a price of $83.68 per share on the same date.

Protagonist Therapeutics Director Buys, Sells Shares Amid Recent Price Volatility.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios